The FDA has approved an updated label for IBTROZI (taletrectinib), a treatment for ROS1-positive non-small cell lung cancer (NSCLC), reflecting a median duration of response of nearly 50 months in TKI-naïve patients from the TRUST-I study. This update confirms long-term clinical benefit and safety with no new safety concerns after extended follow-up. The approval, granted four months ahead of schedule, reinforces IBTROZI as a durable and tolerable treatment option for advanced ROS1+ NSCLC. Nuvation Bio continues to advance global regulatory efforts and ongoing clinical trials for this therapy.
The FDA approval update for IBTROZI® highlights a median duration of response of nearly 50 months in TKI-naïve advanced ROS1-positive non-small cell lung cancer patients. For readers following the health sector, here is Pluang's market snapshot as of Sep 17, 2026 18:11 WIB: out of 91 priced US health stocks, 63 rose and 25 fell. Notable movers include Sana Biotechnology Inc (SANA) at USD 3.00 with 86% sell order activity, Twist Bioscience Corp (TWST) at USD 146.86 with nearly balanced buy/sell activity, and BioNano Genomics Inc (BNGO) at USD 1.55 with 77% sell order activity.
Beta Bionics is evolving into a multi-product diabetes company with the upcoming launch of its FDA-cleared Mint patch pump in the first quarter of 2027. This new product will broaden the company's market reach and accelerate growth through pharmacy c...
The newly launched Pacer Metaurus Enhanced Core Income Autocallable ETF (ACBE) aims to provide higher coupon income through equity-index-linked autocallable notes, even as 10-year Treasury yields hit a cycle high of 5.00%. The fund's performance depe...
Coinbase reported a tough Q2 2026 with revenue down 18.5% due to a 25% drop in crypto spot trading volume amid low Bitcoin prices. Despite this, the company is shifting focus to stablecoins, derivatives, and subscription services, which now make up n...
Quantum Secure Encryption Corp. participated in a Canadian government-supported delegation to the Netherlands, engaging with the European Space Agency and other Dutch organizations to explore collaboration in quantum and space technologies. The compa...
The article argues that true monetization of artificial intelligence requires a breakthrough in consumer hardware, specifically a stationary, powerful home AI companion that acts as an autonomous computational hub. Unlike incremental chatbot subscrip...
